• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, May 23, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Bacterial biofilms, begone

Bioengineer by Bioengineer
August 1, 2017
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Colorado State University/Advanced Functional Materials

FORT COLLINS, COLORADO – By some estimates, bacterial strains resistant to antibiotics ­- so-called superbugs – will cause more deaths than cancer by 2050.

Colorado State University biomedical and chemistry researchers are using creative tactics to subvert these superbugs and their mechanisms of invasion. In particular, they're devising new ways to keep harmful bacteria from forming sticky matrices called biofilms – and to do it without antibiotic drugs.

Researchers from the laboratory of Melissa Reynolds, associate professor of chemistry and the School of Biomedical Engineering, have created a new material that inhibits biofilm formation of the virulent superbug Pseudomonas aeruginosa. Their material, described in Advanced Functional Materials, could form the basis for a new kind of antibacterial surface that prevents infections and reduces our reliance on antibiotics.

Bella Neufeld, the first author and graduate student who led the research, explained that her passion for finding new ways to fight superbugs is motivated by how adaptive and impenetrable they are, especially when they are allowed to form biofilms.

"Biofilms are nasty once they form, and incredibly difficult to get rid of," Neufeld said.

Many people picture bacteria and other microorganisms in their friendlier, free-floating state – like plankton swimming in a high school petri dish. But when bacteria are able to attach to a surface and form a biofilm, they become stronger and more resistant to normal drugs.

In a classic example, cystic fibrosis patients are sickened by hordes of P. aeruginosa bacteria forming a sticky film on the endothelial cells of the patients' lungs. Once those bacteria attach, drugs won't kill them.

Or, a wound can become infected with a bacterial biofilm, making it more difficult for that wound to heal.

Reynolds' research group makes biocompatible devices and materials that resist infection and won't be rejected by the body. In this most recent work, they've designed a material with inherent properties that keep a bacterial film from forming in the first place.

In the lab, they demonstrated an 85 percent reduction in P. aeruginosa biofilm adhesion. They conducted extensive studies showing the reusability of their film. This indicated that its antibacterial properties are driven by something inherent in the material, so its efficacy wouldn't fade in a clinical setting.

They used a material they've worked with before for other antimicrobial applications, a copper-based metal-organic framework that's stable in water. They embedded the copper metal-organic framework within a matrix of chitosan, a material derived from the polysaccharide chitin, which makes up insect wings and shrimp shells. Chitosan is already widely used as a wound dressing and hemostatic agent.

Neufeld says the new biomaterial could form new avenues for antibacterial surfaces. For example, the material could be used for a wound dressing that, instead of gauze, would be made of the chitosan matrix.

The research combined expertise in materials synthesis and biological testing. Co-authors with Neufeld and Reynolds were CSU graduate students Megan Neufeld (no relation) and Alec Lutzke; and Lawrence University undergraduate student Sarah Schweickart.

###

Media Contact

Anne Manning
[email protected]
970-491-7099
@ColoStateNews

Home

Original Source

http://source.colostate.edu/bacterial-biofilms-begone/ http://dx.doi.org/10.1002/adfm.201702255

Share12Tweet8Share2ShareShareShare2

Related Posts

Rising Sightings of Blue and Fin Whales in the South East Atlantic — Biology

Rising Sightings of Blue and Fin Whales in the South East Atlantic

May 23, 2026
New Maps Reveal How European Landscapes Can Simultaneously Promote Climate Action and Biodiversity Conservation — Biology

New Maps Reveal How European Landscapes Can Simultaneously Promote Climate Action and Biodiversity Conservation

May 22, 2026

University of Cincinnati Structural Biologists Achieve World First in Visualizing Crucial Cell Protein

May 22, 2026

Reducing Fertilizer Use Through Strategic Scientific Partnerships

May 22, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    New Study Reveals Plants Can Detect the Sound of Rain

    734 shares
    Share 293 Tweet 183
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    311 shares
    Share 124 Tweet 78
  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    847 shares
    Share 339 Tweet 212
  • Common Food Preservatives Associated with Elevated Blood Pressure and Increased Heart Disease Risk

    55 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Targeting S100A4–TLR4–TGF-β Axis in Diabetic Dupuytren’s

Long-Term AAV9 Gene Therapy for Spinal Muscular Atrophy

Lumacaftor/Ivacaftor Safe, Effective in Preschoolers: Study

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 83 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.